The antifungal drug 5-flucytosine (5FC), a derivative of the nucleobase cytosine, is 30 licenced for treatment of fungal diseases however it is rarely used as a monotherapeutic 31 to treat Aspergillus infection. Despite being potent against other fungal pathogens, 5FC 32 has limited activity against A. fumigatus when standard in vitro assays are used to 33 determine susceptibility. However, in modified in vitro assays where the pH is set to pH 34 5 the activity of 5FC increases significantly. 35
INTRODUCTION 45 46
5FC is a synthetic compound that was originally assessed along with 5-fluorouracil 47 104 105 
Generation of gene deletion constructs 116
Oligonucleotides used for the genetic manipulation of strains are listed in Table S2 . For 117 the generation of knock-out mutants in the A1160P+ background, genes were disrupted 118 by homologous recombination using deletion fragments generated by Fusion PCR 119 following the procedure described recently (24) . Briefly, for the generation of gene 120 deletion fragments, around 1 kb of 5' and 3' flanking region were PCR amplified using 121 primers with designations -1 and -2 (5') and -3 and -4 (3') and fused to an antibiotic 122 resistance cassette (the hygromycin and zeocin resistance cassettes were amplified with 123 hph-FW and hph-RV using pAN 7-1 and pAN 8-1 as template, respectively, as previously 124 described (24) and the pyrithiamine resistance cassette with primers ptrA 5 and ptrA 3 125 using ptrII as template) using the nested primers with designations -N1 and -N2. 126
The hapC deletion mutant in the ATCC46645 background (∆hapC ATCC ) was kindly 127 provided by Prof Dr Hubertus Haas. For the generation of this mutant strain, the 128 bipartite marker technique was used (25). Briefly, the pyrithiamine resistance cassette 129 was released from pSK275 using PstI and HindIII. In the next step hapC 5' and 3' flanking 130 regions were amplified using primer pairs hapC-1/2 and hapC-3/4, respectively. 131 7 inducible promoter PxylP (26) was linked downstream of the hygromycin resistance 141 cassette (Fig S1, hph-PxylP) . Subsequently, a construct including 5' fcyB flanking region, 142 the linker cassette and fcyB coding sequence plus 3' flanking region were amplified via 143
Fusion PCR and transformed into A1160P+. 144
145

Transcriptional profiling and expression analysis 146
Strains were grown in a shaking incubator for 18h in liquid AMM at 37 °C 200 rpm. 147
Subsequently, mycelia were filtered, washed with distilled water and transferred into 148 RPMI pH 5 and pH 7 for 4h using the same incubation conditions. RNA was isolated 149 using TRI Reagent s (Sigma). 10 µg extracted total RNA were digested using RQ1 RNase-150
Free DNase (Promega) and further purified using the RNeasy Mini Kit (Qiagen). For 151 paired-end RNA sequencing, libraries were generated using the TruSeq® Stranded 152 mRNA assay (Illumina, Inc.) according to the manufacturer's protocol. Fastq files were 153 analysed with FastQC and any low-quality reads were trimmed with Trimmomatic. All 154 libraries were aligned to the A. fumigatus A1163 genome assembly (GCA_000150145.1) 155 with the gene annotation from CADRE/Ensembl Fungi v28 using Tophat-2.1.0 and only 156 matches with the best score were reported for each read. Differential expression 157 analysis was performed using Deseq2. Genes with very low levels of expression (with 158 average reads across all conditions <10) were eliminated from our comparative analysis. 159 qPCR was performed in a 7500 Fast Real-Time PCR System (Applied Biosystems) using 160 the iScript One-Step RT-PCR kit with SYBR Green (Cat# 170-8893, Bio-Rad). Primers 161 used for qRT-PCR analysis are listed in Table S2 . Amplification reactions were 162 performed in a final volume of 25 µL using (1.0µL) 0.4µM forward primer, (1.0µL) 0.4 163 µM reverse primer, and 5 ng (5 µL) of total RNA. The PCR cycling conditions were 95°C Northern analysis was carried out as described previously using digoxigenin-labelled 168 probes (27) . 169
170
Reconstitution of ∆fcyB 171
To complement the ∆fcyB mutant phenotype, the plasmid pfcyB REC was generated. The 172 fcyB coding sequence including 1.2 kb 5' and 3' flanking region were amplified using 173 primers fcyB-FW/fcyB-RV. The backbone of the pyrithiamine resistance conferring 174 plasmid pSK275 was amplified as described previously (22). Subsequently both PCR 175 products were fused using Gibson Assembly (NEB) and DNA was propagated in E. coli. 176
177
Fungal transformation 178
For all transformations 2 µg of the respective DNA constructs were used. The plasmid 179 for reconstitution was linearised as illustrated in Fig S2. Transformation using 180 pyrithiamine for selection (0.1µg/ml) was carried out on AMM plus 1M Sucrose, for 181 hygromycin (200µg/ml) and zeocin (150µg/ml) based selection Sabouraud dextrose 182 agar (SAB) supplemented with 1M Sucrose was used. 183
184
Chromatin immunoprecipitation and ChIP-qPCR analysis 185
ChIP-qPCR was performed following the same procedure as described in previously 186 (22). Briefly, the HapC GFP expressing strain (hapC GFP ) was grown in AMM for 18h, 37°C 187 and 200 rpm. The mycelia were harvested by filtration, transferred into RPMI 1640 188 medium (pH7.0) containing 2% glucose, and incubated for 4h at 37 °C with shaking.
9
Cross-linking was carried out using 1% formaldehyde for 20 min. For ChIP-qPCR 190 primers listed in Table S2 were for 5FC resistance. To investigate the role of PacC in 5FC resistance, we generated a pacC 216 deletion mutant (∆pacC) and determined the MIC to 5FC of this strain. Similar to the 217 result obtained for ∆hapC, the ∆pacC strain showed increased susceptibility to 5FC, with 218 an MIC of 12.5 mg/L at pH 7 (Fig. 1) . 219
These data suggest a novel regulatory role of the CBC and PacC in resistance to 5FC. 220 221 Commonalities in the pH, PacC and CBC transcriptional regulons identifies fcyB as 222 the factor promoting pH-dependent 5FC resistance. 223
As susceptibility to 5FC was dramatically increased at low environmental pH or by loss 224 of either PacC or the CBC we hypothesised that the genetic target or targets driving 5FC 225 susceptibility were linked. We therefore assessed the transcriptional profiles of ∆hapC, 226 ∆pacC and their isogenic progenitor at pH 5 and pH 7 by RNAseq to uncover common 227 transcriptional regulons. As the quantitative difference in MIC between conditions was 228 large, we concentrated on genes that were differentially regulated by >4 fold. There 229 were 379 and 407 genes upregulated in ΔhapC and ∆pacC, respectively, at pH 7.0, whilst 230 475 and 262 genes were downregulated. 483 genes were upregulated and 412 231 downregulated by the transition from pH 7 to pH 5. A total of 27 genes were co-232 ordinately upregulated (Table S1 ) and 49 genes downregulated in all three 233 aforementioned data sets. One of the 27 genes upregulated in all data sets was fcyB 234 (AFUB_025700), a gene that encodes a purine-cytosine permease orthologous to yeast 235 Fcy2p (28) which has been previously linked to 5FC uptake and resistance in Candida 236 species but also in Aspergillus nidulans (12, (28) (29) (30) (31) (32) (33) . 237
To confirm the results of our genome-wide transcriptomic study we analysed the 238 expression of fcyB in ΔhapC and ∆pacC mutants at pH 7 and pH 5 by qRT-PCR. Aspredicted by our previous results, fcyB was significantly upregulated at pH 5 (24.5-fold) 240 in the wild-type isolate (Fig. 2) . In ∆pacC transcript levels were significantly increased 241 during growth at both pH 5 (4.0-fold) and pH 7 (34.6-fold) when compared to the 242 isogenic control. Similarly, fcyB expression was upregulated by 11.3-fold at pH 7 in 243 ∆hapC, however, fcyB expression was not significantly increased in ∆hapC in low pH 244 conditions. It is also noteworthy that pH specific regulation of fcyB expression is 245 retained in both the hapC and pacC null mutants. To ensure the results were not unique 246 to one strain background, we evaluated the regulatory role of PacC and HapC in 5FC 247 resistance in a second isolate, ATCC46645. Consistent with data from the A1160P+ 248 strain, fcyB was upregulated at low pH and repression of the gene in the respective 249 mutant strains at neutral pH was lifted (Fig S3) . 250
Combined our transcriptional data indicates that i) the CBC is a negative regulator of 251 fcyB at pH 7 but not at pH 5, ii) PacC is a negative regulator of fcyB at pH 7 and pH 5 and 252
iii) at least one other pH dependent factor is involved in modulating the expression of 253 fcyB, either a negative regulator at pH7 or a positive regulator at pH5. 254
The transcriptional results for fcyB correlate with the 5FC MIC levels for the mutants at 255 pH 5 and 7 (Fig. 1 & Fig. 2 ). The only exception is for ∆hapC at pH 5 where we identified 256 a c. 12.5-25 fold decrease in susceptibility to 5FC (Fig. 1A) however the fcyB transcript 257 was unchanged, which indicates that further factors contribute to 5FC susceptibility in 258 the mutant (Fig. 2) . 259
To further investigate if increased expression of fcyB is the major cause for increased 260 5FC susceptibility in ∆pacC and ∆hapC mutants, the fcyB coding sequence was disrupted 261 in both mutant backgrounds (∆pacC∆fcyB and ∆hapC∆fcyB). Deletion of fcyB 262 dramatically increased resistance in both double mutants to near wild-type and ∆fcyB 263 levels at pH 7 (Fig. 1) . At pH 5 although deletion of fcyB in both the ∆pacC and ∆hapCbackground reduced susceptibility to 5FC by c. 400-fold, ∆pacC∆fcyB was still 265 significantly more susceptible to 5FC than either ∆fcyB or the wt at pH 7.0. 266
Our results suggest that CBC and PacC-mediated regulation of fcyB is a major, but not the 267 sole contributory factor, to 5FC resistance in A. fumigatus. 268
269
CBC mediated regulation of fcyB occurs in a direct manner 270
To identify a direct or indirect regulatory role of HapC in fcyB expression we looked for 271 putative CBC binding sites within 1 kb of the fcyB promoter in ChIP-Seq data generated 272 in our previous work (22). A single binding peak summit was located -570bp relative to 273 the translation start (TLS) (Fig. 3A & 3B) . In close proximity of the peak area we 274 identified two putative CBC binding sites (5'-CCAAT-3') (-663 and -568 relative to the 275
TLS). In vivo binding of the CBC with the promoter was measured employing ChIP-qPCR 276
and revealed significant enrichment of the transcription factor complex at this locus 277 (Fig. 3C) . We have also assessed interaction of PacC with three putative binding sites (-278 977, -1075 and -1294 relative to the TLS) located within 1.5 kb of the fcyB promoter by 279
ChIP qPCR. No significant enrichment for binding at these sites was detected (data not 280 shown). 281
Taken together, these data strongly suggest that the CBC acts as a direct negative 282 regulator of fcyB, however no direct regulatory function could be identified for PacC. 283
284
CBC and PacC independent overexpression of fcyB results in 5FC hypersusceptibility 285
Our results strongly indicate that mutation of PacC and the CBC results in increased 286 susceptibility to 5FC via upregulation of fcyB. To assess if upregulation of fcyB, 287 independent of PacC and CBC activity, could cause reduction in resistance to 5FC, we 288 generated an fcyB tunable mutant (fcyB XYL ). This was achieved by replacing the 289 endogenous promoter with the Penicillium chrysogenum xylose-inducible, glucose-290 repressible promoter PxylP (Fig. 4A) (26) . This system was successfully tested for 291 tunable expression in A. fumigatus in previous studies (34-36). 292
Glucose mediated downregulation of fcyB expression resulted in pH independent 5FC 293 hyperresistance ( Fig. 4B ; fcyB XYL n.i.) whereas xylose mediated induction rendered 294 strain fcyB XYL hypersusceptible (fcyB XYL i.) to 5FC during both low and high pH (Fig. 4B)  295 with MIC levels lower than 0.03 mg/L at pH 7 (Fig. 4C) . 296
Taken together, this data further suggests that transcriptional upregulation of fcyB 297 represents a major contributory factor for 5FC hypersusceptibility. 298 299 DISCUSSION 300
301
In this work, we unveil novel mechanisms mediating 5FC resistance in the opportunistic 302 fungal pathogen A. fumigatus. We show that enhanced expression of the gene encoding 303 the orthologue of the A. nidulans purine-cytosine permease, FcyB, is a major factor 304 contributing to 5FC sensitivity. As in A. nidulans lack of FcyB activity confers 305 hyperresistance (33). We discovered that fcyB, is transcriptionally repressed in high pH 306 environments, illustrating a major reason for the intrinsic resistance to 5FC observed 307 when A. fumigatus isolates are assessed using the standard EUCAST and CLSI 308 methodologies (21, 37). We have, in addition, identified two transcription factors, the 309 CBC and the pH regulatory protein PacC, that orchestrate 5FC resistance via 310 transcriptional repression of fcyB (model see Fig. 5 ). Our data reveals a direct role for 311 the CBC in repression of fcyB at high pH and shows that PacC is a negative regulator ofunidentified factors, transcriptionally governed by both the CBC and PacC but 314 independent of FcyB contribute to 5FC resistance. 315
FcyB is a member of the high-affinity nucleobase cation symporter family 1 (NCS1) and 316 requires H+ ions for the import of its substrate molecules, including the antifungal 317 prodrug 5FC (33, 38, 39) . It has therefore been suggested, that proton availability in 318 acidic environments is a key factor driving increased activity of FcyB and ultimately 319 uptake of 5FC. Our transcriptional data however, cast doubt on this hypothesis. Using a 320 xylose-inducible expression system to uncouple fcyB expression from CBC and PacC 321 regulation, we have demonstrated that overexpression of fcyB alone is sufficient to 322 increase 5FC activity independent of pH (Fig. 5) . 323
324
More than a decade ago the interdependency of 5FC activity with environmental pH was 325 revealed in clinical yeast and mould species including A. fumigatus (7, 19). Despite 326 studies demonstrating the efficacious, monotherapeutic use of 5FC in murine models of 327 aspergillosis, this drug is typically not applied in clinical settings (9, 40). To our 328 knowledge, no data is available to indicate the pH in the lung during aspergillus infection 329 however from studies of other pathological states it has been shown that cellular 330 damage, inflammation and infection can lead to a localised reduction of pH below pH 7 331 Expression of the gene was quantified using ImageJ. 543 wt, wild-type; ∆C, ∆hapC; ∆P, ∆pacC; ATCC, ATCC46645; A1160, A1160P+.
